BioSpace News Archive

Business

Cellares and Cabaletta Bio Partner to Evaluate Automated Manufacturing for CABA-201, Cabaletta’s CD19-CAR T Cell Therapy on Cellares’ Cell Shuttle Platform

Cellares and Cabaletta Bio, Inc. today announced Cabaletta will evaluate Cellares’ automated manufacturing platform, the Cell Shuttle™, through Cellares’ Technology Adoption Partnership (TAP) program.

November 6, 2023
·
8 min read
Business

DiaMedica Therapeutics to Report Third Quarter 2023 Financial Results and Provide a Business Update November 14, 2023

DiaMedica Therapeutics Inc. announced today that its third quarter 2023 financial results will be released after the markets close on Monday, November 13th.

November 6, 2023
·
1 min read
BioMidwest

NorthStar Medical Radioisotopes Announces Participation in Upcoming 2023 Truist Securities Biopharma Symposium

NorthStar Medical Radioisotopes , LLC, today announced that it will participate in the upcoming 2023 Truist Securities Biopharma Symposium being held November 8 to 9, 2023, in New York, NY.

November 6, 2023
·
3 min read
Pharm Country

Schrödinger to Participate in Upcoming Investor Conferences

Schrödinger today announced that management will participate in the following conferences in November.

November 6, 2023
·
1 min read
Inspira™ Announces Israeli Innovation Authority Grant for New VORTX™ Disposable Blood Oxygenation Technology

Inspira™ Technologies OXY B.H.N. Ltd. (Nasdaq: IINN, (Nasdaq: IINNW) (the “Company” or “Inspira Technologies”) is pleased to announce the recent approval of a grant from the Israeli Innovation Authority (IIA) for the groundbreaking VORTX™ Disposable Blood Oxygenation Technology.

November 6, 2023
·
4 min read
Biotech Bay

Qylur Awarded US Air Force AFWERX Phase II SBIR Contract for Mission Adaptive AI for Networks of Autonomous Systems

Qylur announces it has been selected by AFWERX for a Direct-to-Phase II contract in the amount of $1.2 million focused on the SNIM® (Social Network of Intelligent Machines) AI platform to address the most pressing challenges in the Department of the Air Force (DAF).

November 6, 2023
·
3 min read
Drug Development

Boehringer Ingelheim achieves major milestone in chronic kidney disease: aldosterone synthase inhibitor on top of empagliflozin delivers promising results in Phase II trial

Boehringer Ingelheim today announced promising 14-week Phase II data for BI 690517, a novel selective aldosterone synthase inhibitor (ASi).

November 6, 2023
·
8 min read
Inventiva announces a late breaker abstract and two additional abstracts on its lead compound, lanifibranor, at the AASLD The Liver Meeting® 2023

Inventiva announced that the phase II trial led by Dr. Cusi in patients with type two diabetes has been accepted as late breaker, at the upcoming The Liver Meeting® 2023 hosted by the American Association for the Study of Liver Diseases on November 10-14, 2023 in Boston.

November 6, 2023
·
13 min read
Genetown

Apellis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - November 06, 2023

Apellis Pharmaceuticals, Inc. announced that the company approved the grant of equity awards to 20 new employees with a grant date of November 1, 2023, as equity inducement awards outside of the company’s 2017 Stock Incentive Plan and material to the employees’ acceptance of employment with the company.

November 6, 2023
·
2 min read
QIAGEN launches complete Sample to Insight workflow for microbiome research

QIAGEN announced the launch of the Microbiome WGS SeqSets, a comprehensive Sample to Insight workflow designed to provide an easy-to-use solution that maximizes efficiency and reproducibility in microbiome research.

November 6, 2023
·
6 min read